Note: David M. Cordani announced his retirement as CEO of The Cigna Group effective July 1, 2026. He will transition to the role of Executive Chairman. Brian Evanko, the current President and COO, has been named as his successor and will assume the CEO role on July 1, 2026.
David M. Cordani has served as Chairman, President, and Chief Executive Officer of The Cigna Group (NYSE: CI) since 2009, making him one of the longest-serving healthcare CEOs in the Fortune 20. Under his leadership, Cigna transformed from a traditional health insurer into a $275 billion global healthcare services powerhouse through the landmark $67 billion merger with Express Scripts in 2018. Cordani, a 35-year company veteran who joined straight from Coopers & Lybrand in 1991, oversaw the rebranding to “The Cigna Group” in 2023 and built the Evernorth Health Services platform into an industry-leading healthcare services business. On March 3, 2026, The Cigna Group announced that Cordani will retire as CEO effective July 1, 2026, transitioning to Executive Chairman, with Brian Evanko succeeding him.
Read on to discover The Cigna Group CEO email address, David Cordani net worth in 2026, salary and compensation, career history, wife & family, and more.
(Suggested: Aetna CEO Email & Net Worth)

David Cordani — Quick Facts
| David M. Cordani — At a Glance | |
|---|---|
| Full Name | David M. Cordani |
| Position | Chairman, President & Chief Executive Officer |
| Company | The Cigna Group (NYSE: CI) |
| Age | 60 years old (born February 10, 1966) |
| Nationality | American |
| Education | B.S. Accounting, Texas A&M University; MBA, University of Hartford |
| Certifications | CPA (Certified Public Accountant), ChFC (Chartered Financial Consultant) |
| Net Worth (2026) | ~$177 Million+ (stock holdings) |
| Total Compensation (FY2024) | ~$23.3 Million |
| CEO Since | 2009 (retiring July 1, 2026) |
| Headquarters | Bloomfield, Connecticut |
| [email protected] | |
Early Life & Education
David M. Cordani was born on February 10, 1966, and grew up in a multigenerational household in Connecticut. His upbringing instilled strong values of hard work, discipline, and community that would later shape his leadership style in corporate America.
Cordani enrolled at Texas A&M University, where he earned a Bachelor of Science in Accounting in 1988. His time at Texas A&M profoundly influenced him, particularly the university’s deep military culture and traditions. Cordani has spoken publicly about how his Aggie ring serves as a daily reminder of those values. He and his wife Sherry later established the Sherry L. and David M. Cordani ’88 Aggie Veteran Freedom Scholarship to support Aggie veterans and their spouses attending Texas A&M.
Cordani went on to earn a Master of Business Administration (MBA) from the University of Hartford’s Barney School of Business. He also holds two professional designations: Certified Public Accountant (CPA) and Chartered Financial Consultant (ChFC), giving him an unusually comprehensive financial toolkit for a healthcare CEO.
Education Summary
| University | Degree / Program |
|---|---|
| Texas A&M University | B.S. in Accounting (Class of 1988) |
| University of Hartford, Barney School | Master of Business Administration (MBA) |
| Professional Certifications | CPA, ChFC |
Career
David Cordani’s career began at Coopers & Lybrand (now PricewaterhouseCoopers) in 1988, where he worked as a Senior Auditor in the consulting division. Over three years, he gained deep expertise in financial auditing, compliance, and operational advisory services for financial services clients.
In September 1991, Cordani joined Cigna and never left, beginning a career at the company that would span over three decades. He rose through numerous leadership positions across distribution, marketing, clinical management, underwriting, and finance. His ability to bridge financial expertise with healthcare operations set him apart from his peers.
By 2005, Cordani was named President of Cigna HealthCare, the company’s largest business segment, where he oversaw operations serving millions of members. His strong performance led to his appointment as President and Chief Operating Officer of Cigna Corporation in 2008, positioning him as the heir apparent to the CEO role.
Career Timeline
| Period | Role | Organization |
|---|---|---|
| 1988-1991 | Senior Auditor, Consulting | Coopers & Lybrand (now PwC) |
| 1991-2005 | Various Senior Leadership Roles | Cigna Corporation |
| 2005-2008 | President, Cigna HealthCare | Cigna Corporation |
| 2008-2009 | President & COO | Cigna Corporation |
| 2009-Present | Chief Executive Officer | Cigna / The Cigna Group |
| 2022-Present | Chairman of the Board | The Cigna Group |
CEO Role & The Express Scripts Merger
David Cordani became Chief Executive Officer of Cigna in 2009, taking the helm during a period of significant transformation in the U.S. healthcare industry. Over his 17-year tenure as CEO, he has orchestrated a series of strategic moves that fundamentally reshaped the company.
The most transformative moment came in 2018, when Cordani led Cigna’s $67 billion acquisition of Express Scripts, one of the largest healthcare mergers in history. The deal combined Cigna’s health insurance operations with Express Scripts’ pharmacy benefit management (PBM) platform, creating a vertically integrated healthcare services company. Despite regulatory scrutiny and skepticism from some investors, the merger was completed and has since proven to be a strategic masterstroke.
Following the merger, Cordani created Evernorth Health Services, a new platform that houses the company’s pharmacy benefits, care delivery, and data analytics businesses. In 2023, he oversaw the corporate rebranding from “Cigna Corporation” to “The Cigna Group” to better reflect its diversified portfolio. The company now operates through two main segments:
- Evernorth Health Services — Pharmacy benefits (Express Scripts), specialty pharmacy, care delivery, and health analytics
- Cigna Healthcare — Medical, dental, behavioral, vision, and pharmacy benefit plans for employers and individuals
Key Achievement: Under Cordani’s leadership, The Cigna Group’s annual revenue grew from approximately $18 billion in 2009 to $275 billion in 2025, a more than 15-fold increase. The company serves over 190 million customer relationships worldwide.
Leadership & Achievements
David Cordani’s leadership of The Cigna Group has been marked by several notable achievements and strategic initiatives:
- Express Scripts Acquisition (2018) — Completed the $67 billion merger, creating one of the largest healthcare services companies globally
- Revenue Growth — Grew Cigna’s revenue from ~$18B to $275B during his tenure as CEO
- Evernorth Health Services — Built a healthcare services platform that now generates the majority of the company’s revenue
- Corporate Rebranding (2023) — Led the transition from Cigna Corporation to The Cigna Group
- Pharmacy Benefits Innovation — Launched Express Scripts’ new PBM model aligned with industry reforms and FTC settlement requirements
- Consistent Shareholder Returns — Delivered strong adjusted EPS growth and significant share buyback programs throughout his tenure
- Board Leadership — Named Chairman of the Board in 2022, adding governance oversight to his executive responsibilities
Beyond The Cigna Group, Cordani serves on the Board of Directors of General Mills, Inc. and is an active member of the Business Roundtable, where he has contributed to healthcare policy discussions. He has also been a vocal advocate for making healthcare more affordable and accessible.

Personal Life
David Cordani is married to Sherry Cordani, and together they are deeply involved in philanthropic work. The couple established the David and Sherry Cordani Family Foundation, which supports initiatives in health, education, and community vitality. Their foundation has made significant contributions to organizations focused on improving healthcare access and educational opportunities.
Cordani and his wife have two children and reside in Simsbury, Connecticut, a suburban community near The Cigna Group’s Bloomfield headquarters. Despite leading a Fortune 20 company, Cordani is known for maintaining a relatively private personal life.
A devoted alumnus of Texas A&M University, Cordani and Sherry created multiple endowments to support Aggie veterans and their families. The Sherry L. and David M. Cordani ’88 Aggie Veteran Freedom Scholarship reflects their commitment to supporting military-connected students pursuing higher education.
Fun Fact
David Cordani joined Cigna in 1991 and spent his entire 35-year career at the same company — a remarkable feat in an era of frequent executive turnover. His $67 billion acquisition of Express Scripts in 2018 was one of the largest healthcare mergers in history and fundamentally transformed Cigna from a traditional health insurer into a diversified healthcare services powerhouse.
David Cordani Net Worth & Salary
As of 2026, David Cordani’s net worth is estimated at approximately $177 million or more based on his disclosed Cigna Group stock holdings. Some estimates place his total net worth as high as $570 million when including accumulated earnings, other investments, and vested equity over his 17-year tenure as CEO. Cordani has been one of the highest-paid CEOs in the healthcare industry throughout his leadership of the company.
CEO Compensation Breakdown (FY2024)
| Component | Amount (USD) | Share |
|---|---|---|
| Base Salary | $1,573,077 | 6.8% |
| Stock Awards | $15,214,154 | 65.4% |
| Option Awards | $3,340,009 | 14.4% |
| Non-Equity Incentive | $2,720,000 | 11.7% |
| Pension & Deferred Comp. | $31,059 | 0.1% |
| Other Compensation | $372,797 | 1.6% |
| TOTAL | $23,251,096 | 100% |
Key Insight: Over 93% of David Cordani’s compensation is performance-based (stock awards, options, and incentive bonuses), with only about 6.8% coming from base salary. His FY2024 annual incentive was paid at 85% of target, reflecting higher-than-anticipated stop-loss costs. His total compensation increased from $21 million in FY2023 to $23.3 million in FY2024.
The Cigna Group Financial Summary
| Metric | FY2025 | FY2024 | YoY Change |
|---|---|---|---|
| Total Revenue | $274.9B | $247.1B | ▲ +11.3% |
| Net Income | ~$6.0B | $3.4B | ▲ +76.5% |
| Adjusted EPS | $29.84 | $27.33 | ▲ +9.2% |
| Evernorth Revenue | — | $111.8B | ▲ +46% |
| Market Cap | ~$77B | ~$90B | ▼ -14.4% |
| Employees | ~73,000 | ~72,000 | ▲ +1.4% |
| 2026 Revenue Outlook | At least $280 billion | — | |
| 2026 EPS Outlook | At least $30.25 | — | |
The Cigna Group Competitors
The Cigna Group operates in the highly competitive managed healthcare and pharmacy benefits management industries. Key competitors include:
- UnitedHealth Group (UNH) — Largest U.S. health insurer with Optum health services
- CVS Health / Aetna — Integrated pharmacy, health insurance, and retail health
- Elevance Health (formerly Anthem) — Major Blue Cross Blue Shield licensee
- Humana — Focused on Medicare Advantage and senior healthcare
- Centene Corporation — Leading Medicaid managed care organization
- Molina Healthcare — Government-sponsored healthcare programs specialist
How to Contact David Cordani
| Contact Information | |
|---|---|
| Email Address | [email protected] |
| Corporate HQ | 900 Cottage Grove Road, Bloomfield, CT 06002 |
| David M. Cordani — Chairman and CEO, The Cigna Group | |
| Contact Page | thecignagroup.com/contact-us |
Frequently Asked Questions (FAQ)
Who is the CEO of The Cigna Group?
As of March 2026, David M. Cordani serves as Chairman, President, and Chief Executive Officer of The Cigna Group. However, Cordani has announced his retirement as CEO effective July 1, 2026. Brian Evanko, the current President and COO, will succeed him as CEO.
What is David Cordani’s net worth?
David Cordani’s net worth is estimated at $177 million or more based on his disclosed Cigna Group stock holdings. Some estimates place his total wealth as high as $570 million when including accumulated earnings and other assets over his 17-year tenure as CEO.
What is David Cordani’s salary?
David Cordani’s total compensation for fiscal year 2024 was approximately $23.3 million, including a $1.57 million base salary, $15.2 million in stock awards, $3.3 million in option awards, and $2.7 million in non-equity incentive compensation. Over 93% of his pay is performance-based.
How long has David Cordani been CEO of Cigna?
Cordani has been CEO since 2009 — over 17 years, making him one of the longest-serving healthcare CEOs in the Fortune 100. He plans to retire from the role on July 1, 2026, and transition to Executive Chairman.
What is The Cigna Group?
The Cigna Group (formerly Cigna Corporation, rebranded in 2023) is a $275 billion global healthcare services company. It operates through two main segments: Evernorth Health Services (pharmacy benefits, specialty pharmacy, care delivery) and Cigna Healthcare (medical, dental, behavioral, and vision plans). The company serves over 190 million customer relationships worldwide.
What was the Express Scripts merger?
In 2018, Cordani led Cigna’s $67 billion acquisition of Express Scripts, one of the largest healthcare mergers in history. The deal combined Cigna’s health insurance operations with Express Scripts’ pharmacy benefit management platform, creating a vertically integrated healthcare services company and forming the basis for the Evernorth Health Services segment.
Who is replacing David Cordani as CEO?
Brian Evanko, currently President and COO of The Cigna Group, will succeed Cordani as CEO effective July 1, 2026. Evanko has spent nearly three decades at the company, previously serving as CFO and President of Cigna Healthcare. Cordani will become Executive Chairman of the Board.
Conclusion
David M. Cordani’s 17-year tenure as CEO of The Cigna Group represents one of the most transformative leadership periods in the healthcare industry. Starting his career as an auditor at Coopers & Lybrand and joining Cigna in 1991, Cordani rose through the ranks to lead the company through its most consequential era — including the $67 billion Express Scripts merger, the creation of Evernorth Health Services, and the corporate rebranding to The Cigna Group. Under his watch, the company’s revenue grew from $18 billion to $275 billion, and it expanded from a traditional health insurer into a diversified healthcare services leader serving nearly 200 million customers worldwide. As Cordani prepares to hand the reins to Brian Evanko in July 2026, he leaves behind a fundamentally different company — one positioned at the intersection of healthcare delivery, pharmacy services, and data-driven innovation.
Article last updated: March 2026
Disclaimer: All information presented in this article has been compiled from publicly available sources, including SEC filings, official company press releases, and reputable news outlets. This content is provided for informational purposes only and does not constitute financial or investment advice.